1966 related articles for article (PubMed ID: 19875727)
21. A novel monoclonal antibody against the extracellular domain of GPIbbeta modulates vWF mediated platelet adhesion.
Perrault C; Moog S; Rubinstein E; Santer M; Baas MJ; de la Salle C; Ravanat C; Dambach J; Freund M; Santoso S; Cazenave JP; Lanza F
Thromb Haemost; 2001 Nov; 86(5):1238-48. PubMed ID: 11816713
[TBL] [Abstract][Full Text] [Related]
22. A G-quartet oligonucleotide blocks glycoprotein Ib-mediated platelet adhesion and aggregation under flow conditions.
Zhou Z; Bernardo A; Zhu Q; Guan Y; Sun W; Lopez JA; Jing N; Dong JF
Thromb Haemost; 2009 Sep; 102(3):529-37. PubMed ID: 19718474
[TBL] [Abstract][Full Text] [Related]
23. Evidence from limited proteolysis of a ristocetin-induced conformational change in human von Willebrand factor that promotes its binding to platelet glycoprotein Ib-IX-V.
Kang M; Wilson L; Kermode JC
Blood Cells Mol Dis; 2008; 40(3):433-43. PubMed ID: 17977030
[TBL] [Abstract][Full Text] [Related]
24. Cytoplasmic domains of GpIbalpha and GpIbbeta regulate 14-3-3zeta binding to GpIb/IX/V.
Feng S; Christodoulides N; Reséndiz JC; Berndt MC; Kroll MH
Blood; 2000 Jan; 95(2):551-7. PubMed ID: 10627461
[TBL] [Abstract][Full Text] [Related]
25. A functional 14-3-3zeta-independent association of PI3-kinase with glycoprotein Ib alpha, the major ligand-binding subunit of the platelet glycoprotein Ib-IX-V complex.
Mu FT; Andrews RK; Arthur JF; Munday AD; Cranmer SL; Jackson SP; Stomski FC; Lopez AF; Berndt MC
Blood; 2008 May; 111(9):4580-7. PubMed ID: 18299448
[TBL] [Abstract][Full Text] [Related]
26. Characterization of liposomes carrying von Willebrand factor-binding domain of platelet glycoprotein Ibalpha: a potential substitute for platelet transfusion.
Kitaguchi T; Murata M; Iijima K; Kamide K; Imagawa T; Ikeda Y
Biochem Biophys Res Commun; 1999 Aug; 261(3):784-9. PubMed ID: 10441502
[TBL] [Abstract][Full Text] [Related]
27. The cytoplasmic domain of glycoprotein (GP) Ibalpha constrains the lateral diffusion of the GP Ib-IX complex and modulates von Willebrand factor binding.
Dong JF; Li CQ; Sae-Tung G; Hyun W; Afshar-Kharghan V; López JA
Biochemistry; 1997 Oct; 36(41):12421-7. PubMed ID: 9376345
[TBL] [Abstract][Full Text] [Related]
28. Expression of the amino-terminal domain of platelet glycoprotein Ib alpha: exploitation of a calmodulin tag for determination of its functional activity.
Li CQ; Ye P; Cao Zf ; Wang H; Lu L; Nicastro P; Wood E; Robert JJ; Ouwehand WH; Hill F; López JA; Wardell MR
Protein Expr Purif; 2001 Jul; 22(2):200-10. PubMed ID: 11437595
[TBL] [Abstract][Full Text] [Related]
29. Analysis of the roles of 14-3-3 in the platelet glycoprotein Ib-IX-mediated activation of integrin alpha(IIb)beta(3) using a reconstituted mammalian cell expression model.
Gu M; Xi X; Englund GD; Berndt MC; Du X
J Cell Biol; 1999 Nov; 147(5):1085-96. PubMed ID: 10579727
[TBL] [Abstract][Full Text] [Related]
30. von Willebrand factor contained in a high purity FVIII concentrate (Fanhdi) binds to platelet glycoproteins and supports platelet adhesion to subendothelium under flow conditions.
Rivera J; Escolar G; Casamiquela R; Bravo MI; Jorquera JI; Castillo R; Ordinas A; Vicente V
Haematologica; 1999 Jan; 84(1):5-11. PubMed ID: 10091386
[TBL] [Abstract][Full Text] [Related]
31. Structures of glycoprotein Ibalpha and its complex with von Willebrand factor A1 domain.
Huizinga EG; Tsuji S; Romijn RA; Schiphorst ME; de Groot PG; Sixma JJ; Gros P
Science; 2002 Aug; 297(5584):1176-9. PubMed ID: 12183630
[TBL] [Abstract][Full Text] [Related]
32. Regulation of glycoprotein Ib-IX-von Willebrand factor interaction by cAMP-dependent protein kinase-mediated phosphorylation at Ser 166 of glycoprotein Ib(beta).
Bodnar RJ; Xi X; Li Z; Berndt MC; Du X
J Biol Chem; 2002 Dec; 277(49):47080-7. PubMed ID: 12361948
[TBL] [Abstract][Full Text] [Related]
33. Protamine sulphate inhibits platelet membrane glycoprotein Ib-von Willebrand factor activity.
Barstad RM; Stephens RW; Hamers MJ; Sakariassen KS
Thromb Haemost; 2000 Feb; 83(2):334-7. PubMed ID: 10739395
[TBL] [Abstract][Full Text] [Related]
34. Identification of the binding site for an alloantibody to von Willebrand factor which inhibits binding to glycoprotein Ib within the amino-terminal region flanking the A1 domain.
Shibata M; Shima M; Fujimura Y; Takahashi Y; Nakai H; Sakurai Y; Asatani M; Nomura A; Take H; Giddings JC; Yoshioka A
Thromb Haemost; 1999 May; 81(5):793-8. PubMed ID: 10365755
[TBL] [Abstract][Full Text] [Related]
35. Binding of a novel 50-kilodalton alboaggregin from Trimeresurus albolabris and related viper venom proteins to the platelet membrane glycoprotein Ib-IX-V complex. Effect on platelet aggregation and glycoprotein Ib-mediated platelet activation.
Andrews RK; Kroll MH; Ward CM; Rose JW; Scarborough RM; Smith AI; López JA; Berndt MC
Biochemistry; 1996 Sep; 35(38):12629-39. PubMed ID: 8823201
[TBL] [Abstract][Full Text] [Related]
36. Ristocetin and botrocetin involve two distinct domains of von Willebrand factor for binding to platelet membrane glycoprotein Ib.
Girma JP; Takahashi Y; Yoshioka A; Diaz J; Meyer D
Thromb Haemost; 1990 Oct; 64(2):326-32. PubMed ID: 1702906
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of adhesive and signaling functions of the platelet GPIb-V-IX complex by a cell penetrating GPIbalpha peptide.
David T; Ohlmann P; Eckly A; Moog S; Cazenave JP; Gachet C; Lanza F
J Thromb Haemost; 2006 Dec; 4(12):2645-55. PubMed ID: 17100656
[TBL] [Abstract][Full Text] [Related]
38. The 14-3-3zeta-GPIb-IX-V complex as an antiplatelet target.
Andrews RK; Du X; Berndt MC
Drug News Perspect; 2007 Jun; 20(5):285-92. PubMed ID: 17878956
[TBL] [Abstract][Full Text] [Related]
39. Interaction between platelet glycoprotein Ibalpha and filamin-1 is essential for glycoprotein Ib/IX receptor anchorage at high shear.
Williamson D; Pikovski I; Cranmer SL; Mangin P; Mistry N; Domagala T; Chehab S; Lanza F; Salem HH; Jackson SP
J Biol Chem; 2002 Jan; 277(3):2151-9. PubMed ID: 11700320
[TBL] [Abstract][Full Text] [Related]
40. Measurement of von Willebrand factor binding to a recombinant fragment of glycoprotein Ibalpha in an enzyme-linked immunosorbent assay-based method: performances in patients with type 2B von Willebrand disease.
Caron C; Hilbert L; Vanhoorelbeke K; Deckmyn H; Goudemand J; Mazurier C
Br J Haematol; 2006 Jun; 133(6):655-63. PubMed ID: 16704443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
